Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
CONMED Corporation: Organic Growth Is Masked By Divestitures
The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio
CONMED Corporation 2026 Q2 - Results - Earnings Call Presentation
Why Are CONMED (CNMD) Shares Soaring Today
Piper Sandler Reiterates Neutral on Conmed, Raises Price Target to $45
Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46
CONMED Q2 Earnings Call Highlights
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
Conmed (CNMD) Reports Q2 Earnings: What Key Metrics Have to Say
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
CONMED (CNMD) Surges After Q2 Earnings Beat and Raised EPS Outlook
CONMED’s (NYSE:CNMD) Q2 CY2026: Beats On Revenue, Stock Soars
CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.